Evaluating the Understandability and Actionability of Web-Based Education Materials for Patients Taking Non-vitamin K Oral Anticoagulants

被引:11
作者
Yiu, Angela [1 ]
Ng, Kingsley K. [2 ]
Lee, Vincent W. [2 ,3 ]
Bajorek, Beata, V [1 ]
机构
[1] Univ Technol, Grad Sch Hlth Pharm, Sydney, NSW, Australia
[2] Westmead Hosp, Dept Renal Med, Westmead, NSW, Australia
[3] Univ Sydney, Fac Med & Hlth, Sydney Med Sch, Sydney, NSW, Australia
关键词
patient education; internet; health communication; search engines; websites; WRITTEN DRUG INFORMATION; HEALTH INFORMATION; LITERACY; INTERNET; MANAGEMENT; TOOL;
D O I
10.1007/s43441-019-00079-1
中图分类号
R-058 [];
学科分类号
摘要
Background: More patients are now taking high-risk medicines such as non-vitamin K oral anticoagulants (NOACs). Hence, patient education materials need to be in an understandable format so that they can be empowered to act on their knowledge. Factors such as health literacy and the design of the medicine information material may influence the patient's ability to understand and act on key information. Method: The PRISMA checklist was used to inform the study design. A structured search was conducted to obtain all freely accessible online educational resources designed for patients about the non-vitamin K antagonists (NOACs) during August 2018. Three search engines were used: Google, Yahoo! and Bing, using the search terms "NOAC" and "anticoagulant" combined with "patient/consumer information and patient/consumer resources."We applied the Patient Education Materials Assessment Tool (PEMAT) to evaluate web-based patient education materials in terms of understandability and actionability for patients taking NOACs. Results: Of the 35 materials included, the majority of the materials (n = 32, 91%) were rated as highly understandable ), and more than three-quarters of all the materials (n = 29, 83%) were rated as poorly actionable (PEMAT score <70%). For understandability, the majority of materials neither provided a summary of the key points nor used visual aids for several items such as simple tables, illustrations, and photographs. For actionability, few materials provided a tangible tool, such as a checklist, to prompt the user into action (n = 4). Few used visual aids such as nonverbal cues to the written instructions (n = 4). Conclusion: To improve the understandability and actionability of most of the NOAC patient education materials, there is a need to include more summaries of information, visual aids, and tangible tools such as checklists. Further research is warranted where patients are involved in providing feedback on the design of medicine information materials for NOACs.
引用
收藏
页码:476 / 483
页数:8
相关论文
共 50 条
  • [41] Safety and Efficacy of Underdosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation
    Yamaji, Hirosuke
    Murakami, Takashi
    Hina, Kazuyoshi
    Higashiya, Shunichi
    Kawamura, Hiroshi
    Murakami, Masaaki
    Kamikawa, Shigeshi
    Komatsubara, Issei
    Kusachi, Shozo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2017, 69 (02) : 118 - 126
  • [42] Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and colorectal cancer: a single-center experience
    Stepien, Konrad
    Nowak, Karol
    Zalewski, Jaroslaw
    Undas, Anetta
    KARDIOLOGIA POLSKA, 2019, 77 (12) : 1186 - 1189
  • [43] Special considerations for therapeutic choice of non-vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation
    Okumura, Ken
    Hori, Masatsugu
    Tanahashi, Norio
    Camm, A. John
    CLINICAL CARDIOLOGY, 2017, 40 (02) : 126 - 131
  • [44] Updated EHRA practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation
    Szymanski, Filip M.
    KARDIOLOGIA POLSKA, 2016, 74 : 99 - 117
  • [45] Non-vitamin K oral anticoagulants versus vitamin K antagonists in post transcatheter aortic valve replacement patients with clinical indication for oral anticoagulation: A meta-analysis
    Yi-feng Chen
    Liu, Fei
    Xi-wen Li
    Hou-jing Zhang
    Yi-ge Liu
    Lin, Lu
    CLINICAL CARDIOLOGY, 2022, 45 (04) : 401 - 406
  • [46] Over 10 years of non-vitamin K antagonist oral anticoagulants: highlights, challenges, and future developments
    De Caterina, Raffaele
    Chiusolo, Simona
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2025, 27 : i6 - i11
  • [47] Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial
    De Caterina, Raffaele
    Camm, A. John
    EUROPACE, 2016, 18 (01): : 6 - 11
  • [48] Overview of Systematic Reviews of Non-Vitamin K Oral Anticoagulants in Atrial Fibrillation Evidence of Publication Overlap
    Doundoulakis, Ioannis
    Antza, Christina
    Apostolidou-Kiouti, Fani
    Akrivos, Evangelos
    Karvounis, Haralambos
    Kotsis, Vasilios
    Haidich, Anna-Bettina
    Giannakoulas, George
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2018, 11 (12): : e004769
  • [49] The non-vitamin K antagonist oral anticoagulants and heparin-induced prolongation of the activated coagulation time
    Negro, Francesco
    Caravelli, Paolo
    Morganti, Riccardo
    Casini, Monica
    Ruocco, Lucia
    Tripodi, Armando
    De Caterina, Raffaele
    VASCULAR PHARMACOLOGY, 2022, 144
  • [50] Mechanisms of action and clinical use of specific reversal agents for non-vitamin K antagonist oral anticoagulants
    Andresen, Kristoffer
    Atar, Dan
    Gjertsen, Erik
    Ghanima, Waleed
    Roseth, Svein
    Johansen, Odd Erik
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2018, 52 (03) : 156 - 162